Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
PIMSTONE SIMON N.
Director at Xenon Pharmaceuticals. Filing since 10 Aug 2017.
CIK 0001620084
Company
Date
Role
Action
Shares
Amount
Of holding
XENE
Xenon Pharmaceuticals Inc.
1 Jun 2023
Director
Sold at will
31,713
$1.23M
84.1%
XENE
Xenon Pharmaceuticals Inc.
31 May 2023
Director
Sold at will
62,526
$2.42M
91.2%
XENE
Xenon Pharmaceuticals Inc.
30 May 2023
Director
Sold at will
37,006
$1.45M
67.3%
XENE
Xenon Pharmaceuticals Inc.
7 Mar 2023
Director
Sold, plan not stated
19,232
$711.20K
36.1%
XENE
Xenon Pharmaceuticals Inc.
16 Aug 2022
Director
Sold, plan not stated
52,058
$2.00M
89.7%
XENE
Xenon Pharmaceuticals Inc.
15 Aug 2022
Director
Sold, plan not stated
33,942
$1.28M
36.9%
XENE
Xenon Pharmaceuticals Inc.
12 Aug 2022
Director
Sold, plan not stated
91,135
$3.49M
49.8%
XENE
Xenon Pharmaceuticals Inc.
8 Mar 2022
Director
Sold, plan not stated
14,551
$375.64K
7.4%
XENE
Xenon Pharmaceuticals Inc.
7 Mar 2022
Director
Sold, plan not stated
31,086
$948.26K
13.6%
XENE
Xenon Pharmaceuticals Inc.
4 Mar 2022
Director
Sold, plan not stated
9,325
$285.43K
4.2%
XENE
Xenon Pharmaceuticals Inc.
15 Nov 2021
Director
Sold, plan not stated
17,557
$550.06K
7.7%
XENE
Xenon Pharmaceuticals Inc.
1 Jun 2020
CEO
Sold, plan not stated
3,000
$43.29K
1.2%
XENE
Xenon Pharmaceuticals Inc.
29 May 2020
CEO
Sold, plan not stated
5,000
$69.95K
1.9%
XENE
Xenon Pharmaceuticals Inc.
20 Sep 2019
CEO
Sold, plan not stated
10,395
$98.86K
3.9%
XENE
Xenon Pharmaceuticals Inc.
10 Aug 2017
President & CEO
Bought
6,000
$17.40K
2.8%
15 decisions on file.
